ArticleBMC infectious diseases2025
Association between body mass index and the prognosis of community-acquired pneumonia in patients with nontuberculous mycobacterial pulmonary disease: a retrospective cohort study using a nationwide inpatient database.
Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- High prevalence of malnutrition and sarcopenia in patients with NTM pulmonary disease: results from an Italian prospective multicentre study.Respiratory research · 2026Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundNontuberculous mycobacterial pulmonary disease (NTM-PD) is a chronic, debilitating infection that predominantly affects patients with a low body mass index (BMI) and leads to progressive destruction of lung parenchyma. Although pneumonia is a common cause of death among patients with NTM-PD, information on its prognosis is scarce. We evaluated the association between BMI and outcomes in patients with NTM-PD who were hospitalized for community-acquired pneumonia (CAP).
methodsUsing the Japanese Diagnosis Procedure Combination database, we identified patients with NTM-PD hospitalized for CAP between April 1, 2012, and March 31, 2020, prior to the coronavirus disease 2019 epidemic in Japan. We evaluated in-hospital mortality as the primary outcome, and length of hospital stay and readmission due to CAP within 1 year as secondary outcomes. Restricted cubic spline regression models were used to evaluate the impact of BMI as a continuous variable on the study outcomes, adjusting for potential confounders.
resultsWe included 13,302 patients (median age: 79 years [interquartile range {IQR} 72-85]; women: 63.7%; median BMI: 17.6 kg/m
conclusionsThese findings indicate that assessing BMI may play a critical role in stratifying risk and optimizing management of CAP in patients with NTM-PD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.